1 Min Read
March 22 (Reuters) - SSY Group Ltd:
* OBTAINED APPROVALS FOR DRUG PRODUCTION AND REGISTRATION FOR HEMOFILTRATION REPLACEMENT FLUID FROM CHINA FDA Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.